OrbiMed’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

OrbiMed’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,945,192	Closed	-$19M	–	144
2023 Q2	$19M	Hold	4,945,192	–	–	0.35%	71
2023 Q1	$14.9M	Hold	4,945,192	–	–	0.29%	76
2022 Q4	$10.1M	Hold	4,945,192	–	–	0.19%	75
2022 Q3	$17.1M	Hold	4,945,192	–	–	0.32%	70
2022 Q2	$20.8M	Hold	4,945,192	–	–	0.38%	61
2022 Q1	$15M	Hold	4,945,192	–	–	0.24%	80
2021 Q4	$23M	Hold	4,945,192	–	–	0.3%	81
2021 Q3	$38.1M	Hold	4,945,192	–	–	0.42%	66
2021 Q2	$42.5M	Hold	4,945,192	–	–	0.43%	62
2021 Q1	$56.2M	Buy	+4,945,192	New	+$77.6M	0.53%	54

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $914M AUM

OrbiMed's DBTX Position: Q3 2023 in Review

OrbiMed sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 4,945,192 shares — an estimated $19M sold.

OrbiMed first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $56.2M in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

OrbiMed reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
OrbiMed sold 4,945,192 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $19M.
OrbiMed first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
OrbiMed's Decibel Therapeutics, Inc. Common Stock position peaked at $56.2M in Q1 2021.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on OrbiMed's 13F filing for Q3 2023, filed 14 Nov 2023.